SEC Form 4 · accession 0001246360-16-004369
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph E Turk Jr.
Officer — President
Period of report
Feb 4, 2016
Accepted (ET)
Feb 5, 2016 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 4, 2016 | M | 991 | $2.11 | A | 109,654 | D | |
| Common Stock | Feb 4, 2016 | S | 991 | $19.60 | D | 108,663 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $2.11 | Feb 4, 2016 | M | 991 | D | Apr 5, 2009 | Mar 4, 2016 | Common Stock | 991 | 1,983 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2015.